Opko Health financials
$1.62−0.61%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $163.6M | $124.2M | $148.4M | $151.7M | $156.8M | $150.0M | $183.6M | $173.6M | $182.2M | $173.7M | $181.9M | $178.6M |
| Gross profit | $80.0M | $45.8M | $64.0M | $49.9M | $49.4M | $42.6M | $84.7M | $40.1M | $51.7M | $42.1M | $44.7M | $47.7M |
| Gross margin | 48.9% | 36.8% | 43.1% | 32.9% | 31.5% | 28.4% | 46.1% | 23.1% | 28.4% | 24.2% | 24.6% | 26.7% |
| Operating income | -$25.0M | -$51.0M | -$38.3M | -$53.5M | -$60.0M | -$67.2M | -$33.1M | -$107.3M | -$61.7M | -$71.5M | -$69.0M | -$64.4M |
| Net income | -$8.4M | -$54.8M | -$31.3M | $21.6M | -$148.4M | -$67.6M | $14.0M | $24.9M | -$10.3M | -$81.8M | -$66.5M | -$84.5M |
| Net margin | −5.1% | −44.2% | −21.1% | 14.3% | −94.7% | −45.1% | 7.6% | 14.3% | −5.7% | −47.1% | −36.5% | −47.3% |
| Diluted EPS | $-0.01 | $-0.07 | $-0.04 | $0.03 | $-0.19 | $-0.10 | $0.04 | $0.03 | $-0.01 | $-0.12 | $-0.09 | $-0.11 |
| EBITDA | -$2.6M | -$28.8M | -$15.9M | -$30.8M | -$37.0M | -$43.7M | -$9.1M | -$83.1M | -$37.5M | -$45.7M | -$43.1M | -$39.2M |
| Operating cash flow | -$43.5M | -$19.3M | -$25.9M | -$34.6M | -$83.4M | -$34.6M | -$44.4M | -$77.1M | -$26.4M | -$35.6M | -$38.3M | $33.2M |
| Free cash flow | -$46.5M | -$21.1M | -$28.6M | -$37.8M | -$86.7M | -$37.7M | -$49.8M | -$85.0M | -$33.7M | -$40.0M | -$41.3M | $29.0M |
| Diluted shares | 755.3M | 758.9M | 765.0M | 779.9M | 788.0M | 671.6M | 373.6M | 998.4M | 697.2M | 706.9M | 752.3M | 751.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $300.8M | $341.9M | $369.1M | $415.2M | $271.7M | $436.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $347.3M | $343.7M | $341.7M | $341.7M | $340.5M | $436.4M |
| Total assets | $1.83B | $1.86B | $1.93B | $2.00B | $1.97B | $2.13B |
| Total liabilities | $645.3M | $652.2M | $664.0M | $690.0M | $676.1M | $816.7M |
| Shareholders' equity | $1.18B | $1.20B | $1.27B | $1.31B | $1.30B | $1.31B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology